SentiAR

Executive Summary

SentiAR is a St. Louis-based digital health company developing an augmented reality (AR) platform to enhance visualization during minimally invasive interventional procedures. Founded in 2016, the company aims to improve surgical precision and patient outcomes by providing real-time, 3D holographic guidance to clinicians. SentiAR's technology overlays critical anatomical data onto the physician's field of view, reducing the need for multiple screens and enabling more intuitive navigation. This addresses a growing trend toward less invasive surgeries, which offer faster recovery and smaller incisions, directly aligning with the needs of cardiologists, radiologists, and other specialists. With a strong intellectual property portfolio and early clinical validation, SentiAR is positioned to disrupt the traditional interventional workflow. The market for AR in healthcare is expanding rapidly, driven by increasing demand for minimally invasive procedures and digital transformation in operating rooms. SentiAR targets a multi-billion-dollar opportunity in cardiovascular and neurovascular interventions. The company has likely secured initial funding from angel investors or grants and is now pursuing Series A financing to support regulatory approvals and commercial launch. Key milestones include regulatory clearance (FDA 510(k)) and strategic partnerships with medical device manufacturers. SentiAR's platform has the potential to become a standard tool in interventional suites, reducing procedure times and complications. With a focused strategy and experienced team, SentiAR is well-positioned for near-term growth.

Upcoming Catalysts (preview)

• Q3 2026Series A Funding Announcement75% success
• Q4 2026FDA 510(k) Clearance for AR Visualization System60% success
• Q3 2026Strategic Partnership with Major Medical Device Company50% success